Overall, these findings elucidated that pharmacological inhibition of MELK effectively hampered the tumorigenesis and progression of HCC, and the combination with RT treatment is profited to strengthen the antitumoral effect. This evidence concerns the gene MELK and hepatocellular carcinoma.